Reproductive-rights groups push against Kennedy's mifepristone review  

Reproductive-rights advocates are pushing back against the review of the abortion medication mifepristone ordered by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.  

Kennedy directed the Food and Drug Administration (FDA) to review the medication during a Senate hearing Wednesday because of findings laid out in a new study conducted by the Ethics and Public Policy Center (EPPC), a conservative think tank. 

Advocates say Kennedy is using inaccurate data on the...